Disease progression in chronic hepatitis C: Modifiable and nonmodifiable factors

被引:163
|
作者
Missiha, Sharif B. [1 ]
Ostrowski, Mario [1 ]
Heathcote, E. Jenny [1 ]
机构
[1] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
关键词
D O I
10.1053/j.gastro.2008.02.069
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The hepatic complications of chronic hepatitis C (CHC) usually occur only after progression to cirrhosis has taken place. Progression to cirrhosis, however, is extremely variable and depends on a broad set of host and viral factors that modify the rate at which fibrosis develops in a given individual. Despite their inherent limitations, studies of the natural history of CHC have identified several nonmodifiable factors associated with disease progression. These include age at acquisition of infection, sex, and race. More recent reports suggest important roles for host genetic polymorphisms and viral factors. Of greater immediate relevance to patients and their clinicians are the potentially modifiable factors, which include excessive alcohol consumption; smoking (tobacco and marijuana); insulin resistance; and coinfection with hepatitis B virus, human immunodeficiency virus type 1, or schistosomiasis. Unfortunately, to date, there are no reliable predictive models that can accurately estimate the risk of CHC disease progression.
引用
收藏
页码:1699 / 1714
页数:16
相关论文
共 50 条
  • [1] Factors associated with severity and disease progression in chronic hepatitis C
    Tassopoulos, NC
    Papatheodoridis, GV
    Katsoulidou, A
    Delladetsima, JK
    Sypsa, V
    Touloumi, G
    Nikandros, M
    Hatzakis, A
    HEPATO-GASTROENTEROLOGY, 1998, 45 (23) : 1678 - 1683
  • [2] Gout A Review of Nonmodifiable and Modifiable Risk Factors
    MacFarlane, Lindsey A.
    Kim, Seoyoung C.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2014, 40 (04) : 581 - +
  • [3] Host genetic factors influence disease progression in chronic hepatitis C
    Powell, EE
    Edwards-Smith, CJ
    Hay, JL
    Clouston, AD
    Crawford, DH
    Shorthouse, C
    Purdie, DM
    Jonsson, JR
    HEPATOLOGY, 2000, 31 (04) : 828 - 833
  • [4] Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer’s disease
    Jia-jia Liu
    Yun-fan Long
    Peng Xu
    Hai-dong Guo
    Guo-hong Cui
    Alzheimer's Research & Therapy, 15
  • [5] Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer's disease
    Liu, Jia-jia
    Long, Yun-fan
    Xu, Peng
    Guo, Hai-dong
    Cui, Guo-hong
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [6] Hepatitis C virus, rheumatoid factors, and disease progression
    Wang, CH
    Flehmig, B
    Tschen, SY
    LANCET, 1998, 351 (9098): : 294 - 294
  • [7] Analysis of modifiable and nonmodifiable risk factors in patients undergoing pituitary surgery
    Shahrestani, Shane
    Ballatori, Alexander M.
    Chen, Xiao T.
    Ton, Andy
    Strickland, Ben A.
    Brunswick, Andrew
    Zada, Gabriel
    JOURNAL OF NEUROSURGERY, 2021, 134 (06) : 1816 - 1823
  • [8] Factors Influencing the Rate of Fibrosis Progression in Chronic Hepatitis C
    Conrado M. Fernández-Rodriguez
    Maria Luisa Gutiérrez
    Pilar López Serrano
    José L. Lledó
    Cecilio Santander
    Teresa Pérez Fernández
    Esperanza Tomás
    Guillermo Cacho
    Manuel Nevado
    Maria Luisa Casas
    Digestive Diseases and Sciences, 2004, 49 : 1971 - 1976
  • [9] Factors influencing the rate of fibrosis progression in chronic hepatitis C
    Fernández-Rodriguez, CM
    Gutiérrez, ML
    Serrano, PL
    Lledó, JL
    Santander, C
    Fernández, TP
    Tomás, E
    Cacho, G
    Nevado, M
    Casas, ML
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (11-12) : 1971 - 1976
  • [10] Factors influencing liver disease progression in chronic hepatitis B
    Liaw, Yun-Fan
    Sollano, Jose D.
    LIVER INTERNATIONAL, 2006, 26 : 23 - 29